Publication
2nd Circuit defers to executive will on application of sovereign immunity
The Second Circuit recently held that federal common law protections of sovereign immunity did not preclude prosecution of a state-owned foreign corporation.
Author:
United States | Publication | February 18, 2022
On February 17, 2022, federal OSHA announced its initiative urging healthcare and related industries to take immediate actions to help make 2022 safer for their employees. OSHA noted an almost 250 percent increase in injury and illness incidence rates among healthcare and social assistance workers commencing in 2020, largely attributed to the COVID pandemic, and leading to combined totals greater than any other American industry.
To that end, OSHA continues to work on its final standard to protect healthcare workers from COVID. In the interim, OSHA emphasizes that employers must continue to comply with their obligations under the General Duty Clause, and the Personal Protective Equipment, Respiratory Protection and other relevant standards to protect employees from COVID hazards in the workplace.
Moreover, OSHA states that employers should create and implement proactive safety and health programs that address recognized hazards, training and preventive measures to keep workers safe. Companies are encouraged to utilize local OSHA On-Site Consultation personnel (1-800-321-OSHA (6742) and OSHA's program website) to discuss program development and conduct on-site safety and health evaluations.
Publication
The Second Circuit recently held that federal common law protections of sovereign immunity did not preclude prosecution of a state-owned foreign corporation.
Publication
Facing the fast-growing development of AI across the globe, particularly Generative AI (GenAI), the G7 competition authorities and policymakers (Canada, France, Germany, Japan, Italy, the UK and the US) and the European Commission met in Italy on 3-4 October 2024 to discuss the main competition challenges raised by these new technologies in digital markets.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023